Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
11 2020
Historique:
received: 10 05 2019
revised: 07 11 2019
accepted: 11 11 2019
pubmed: 26 5 2020
medline: 15 4 2021
entrez: 26 5 2020
Statut: ppublish

Résumé

Early-stage Hodgkin lymphoma (HL) is a highly curable disease but the treatment can induce late complications many years later. Irradiation of the healthy heart is inevitable during radiation treatment of mediastinal sites. We developed a novel method to induce a prolonged apnea-like state that can help decrease the dose to organs at risk during radiation therapy. We present the results of the first 8 HL patients treated routinely with percussion assisted radiation therapy (PART) in our clinic. We used a newly developed high-frequency non-invasive ventilation system to suppress respiratory motion for prolonged periods and push the heart away from the treated volume. All 8 patients were able to rapidly learn the technique and had an advantage to be treated by PART. We lowered the mean heart dose by an average of 3 Gy with similar target coverage compared to a classical free breathing treatment plan. They were all treated for 15 radiotherapy sessions by PART without any notable side effects. Percussion assisted radiation therapy can be used routinely to reduce the dose to the heart in Hodgkin lymphoma.

Sections du résumé

BACKGROUND AND PURPOSE
Early-stage Hodgkin lymphoma (HL) is a highly curable disease but the treatment can induce late complications many years later. Irradiation of the healthy heart is inevitable during radiation treatment of mediastinal sites. We developed a novel method to induce a prolonged apnea-like state that can help decrease the dose to organs at risk during radiation therapy. We present the results of the first 8 HL patients treated routinely with percussion assisted radiation therapy (PART) in our clinic.
MATERIAL AND METHODS
We used a newly developed high-frequency non-invasive ventilation system to suppress respiratory motion for prolonged periods and push the heart away from the treated volume.
RESULTS
All 8 patients were able to rapidly learn the technique and had an advantage to be treated by PART. We lowered the mean heart dose by an average of 3 Gy with similar target coverage compared to a classical free breathing treatment plan. They were all treated for 15 radiotherapy sessions by PART without any notable side effects.
CONCLUSIONS
Percussion assisted radiation therapy can be used routinely to reduce the dose to the heart in Hodgkin lymphoma.

Identifiants

pubmed: 32448409
pii: S0167-8140(19)33475-9
doi: 10.1016/j.radonc.2019.11.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-168

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

André-Dante Durham (AD)

Department of Oncology, Division of Radiation Oncology, Lausanne University Hospital and University of Lausanne, Switzerland.

Alban Lovis (A)

Department of Pulmonology, Lausanne University Hospital and University of Lausanne, Switzerland.

Julien Simons (J)

Department of Physiotherapy, Lausanne University Hospital and University of Lausanne, Switzerland.

Olivier Long (O)

Department of Physiotherapy, Lausanne University Hospital and University of Lausanne, Switzerland.

Flore Buela (F)

Department of Physiotherapy, Lausanne University Hospital and University of Lausanne, Switzerland.

Adam Ogna (A)

Department of Pulmonology, Lausanne University Hospital and University of Lausanne, Switzerland; Department of Pulmonology, Hospital La Carità, Locarno, Switzerland.

Raphaël Jumeau (R)

Department of Oncology, Division of Radiation Oncology, Lausanne University Hospital and University of Lausanne, Switzerland.

Anne Cairoli (A)

Department of Oncology, Division of Hematology, Lausanne University Hospital and University of Lausanne, Switzerland.

Susana Rocha Do Carmo Leal (S)

Department of Oncology, Division of Radiation Oncology, Lausanne University Hospital and University of Lausanne, Switzerland.

Michele Zeverino (M)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Switzerland.

David Patin (D)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Switzerland.

Véronique Vallet (V)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Switzerland.

Raphaël Moeckli (R)

Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Switzerland.

Jean Bourhis (J)

Department of Oncology, Division of Radiation Oncology, Lausanne University Hospital and University of Lausanne, Switzerland. Electronic address: Jean.Bourhis@chuv.ch.

Mahmut Ozsahin (M)

Department of Oncology, Division of Radiation Oncology, Lausanne University Hospital and University of Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH